PUBLICATION

A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation

Authors
Doll, L., Welte, K., Skokowa, J., Bajoghli, B.
ID
ZDB-PUB-240514-6
Date
2024
Source
Blood advances   8(15): 4050-4065 (Journal)
Registered Authors
Bajoghli, Baubak
Keywords
none
MeSH Terms
  • Animals
  • Apoptosis
  • Congenital Bone Marrow Failure Syndromes*/genetics
  • Disease Models, Animal
  • Hematopoiesis/genetics
  • Humans
  • Membrane Proteins/genetics
  • Membrane Proteins/metabolism
  • Mutation
  • Neutropenia*/congenital
  • Neutropenia*/genetics
  • Receptors, Granulocyte Colony-Stimulating Factor/genetics
  • Receptors, Granulocyte Colony-Stimulating Factor/metabolism
  • Signal Transduction*
  • Unfolded Protein Response*
  • Zebrafish*
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism
PubMed
38739706 Full text @ Blood Adv
Abstract
A variety of autosomal recessive mutations in the JAGN1 gene cause severe congenital neutropenia (CN). However, the underlying pathomechanism remains poorly understood, mainly due to the limited availability of primary hematopoietic stem cells from JAGN1-CN patients and the absence of animal models. In this study, we aimed to address these limitations by establishing a zebrafish model of JAGN1-CN. We found two paralogs of the human JAGN1 gene, jagn1a and jagn1b, which play distinct roles during zebrafish hematopoiesis. Using various approaches such as morpholino-based knockdown, CRISPR/Cas9-based gene-editing, and misexpression of a jagn1b harboring a specific human mutation, we successfully developed neutropenia while leaving other hematopoietic lineages unaffected. Further analysis of our model revealed significant upregulation of apoptosis and genes involved in unfolded protein response (UPR). However, neither UPR nor apoptosis is the primary mechanism leading to neutropenia in zebrafish. Instead, Jagn1b has a critical role in G-CSFR signaling and steady-state granulopoiesis, shedding light on the pathogenesis of neutropenia associated with JAGN1 mutations. The establishment of a zebrafish model for JAGN1-CN represents a significant advancement in understanding the specific pathological pathways underlying the disease. This model provides a valuable in vivo tool for further investigation and exploration of potential therapeutic strategies.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping